BioNTech SE aims to improve vaccine supply in Africa by developing and delivering turnkey messenger RNA (mRNA) manufacturing facilities based on a container solution, the company said in a Feb. 16, 2022 press release. This modular-facility approach is designed to create scalable vaccine production that could become a decentralized manufacturing network.
BioNTech presented the container solution named “BioNTainer” at a meeting attended by key partners including the presidents of Ghana, Rwanda, and Senegal; the director-general of the World Health Organization; the director of the Africa Centers for Disease Control and Prevention; and the Federal Minister of Economic Cooperation and Development of Germany.
